Desmopressin is a safe drug for the treatment of enuresis

References

• Perlmutter D. Enuresis. Clinical pediatric urology, 2nd ed, PP Kelalis, LR King, AB Belman. WB Saunders Co, Philadelphia, PA 1985; 311–25
   Google Scholar
• Chiozza ML, Berardinelli L, Caione P, Del Gado R, Ferrara P, Giorgi PL, et al. An Italian epidemiologic multicenter study on nocturnal enuresis. Br J Urol 1998; 81(Suppl 3)86–9
   PubMedGoogle Scholar
• Ritting S, Schaumburg H, Schmidt F, Hunsballe JM, Hansen AF, Kirk J, et al. Long-term home studies of water balance in patients with nocturnal enuresis. Scand J Urol Nephrol Suppl 1997; 183: 25–6
   PubMedGoogle Scholar
• Hunsballe JM, Hansen TK, Ritting S, Norgaard JP, Pedersen EB, Djurhuus JC. Polyuric and non-polyuric bedwetting—pathogenic differences in nocturnal enuresis. Scand J Urol Nephrol Suppl 1995; 173: 77–8
   PubMedGoogle Scholar
• De Jonge GA. Epidemiology of enuresis: a survey of the literature. Bladder control and enuresis, I Kolvin, RC MacKeith, SR Meadow. Lippincott, Philadelphia, PA 1973; 39–46
   Google Scholar
• Hagglof B, Andren O, Bergstrom E, Marklund L, Wendelius M. Self-esteem in children with nocturnal enuresis and urinary incontinence: improvement of self-esteem after treatment. Eur Urol 1998; 33(Suppl 3)16–9
   PubMedGoogle Scholar
• Lackgren G, Hjalmas K, van Gool J, von Gontard A, de Gennaro M, Lottmann H, et al. A suggestion for a European treatment strategy. Acta Paediatr 1999; 88: 679–90
   PubMed Web of Science ®Google Scholar
• Terho P. Desmopressin in nocturnal enuresis. J Urol 1991; 145: 818–20
   PubMed Web of Science ®Google Scholar
• Hjalmas K, Bengtsson B. Efficacy, safety and dosing of desmopressin for nocturnal enuresis in Europe. Clin Pediatr (Phila) 1993; Spec No: 19–24
   PubMedGoogle Scholar
• Chiozza ML, Del Gado R, Di Toro R, Ferrara P, Fois A, Giorgi PL, et al. Italian Multicentre Open Trial on DDAVP spray in nocturnal enuresis. Scand J Urol Nephrol 1999; 33: 42–8
   PubMedGoogle Scholar
• Hjalmas K, Hanson E, Hellstrom AL, Kruse S, Sillen U. Long-term treatment with desmopressin in children with primary monosymptomatic nocturnal enuresis: an open multicentre study. Swedish Enuresis Trial (SWEET) Group. Br J Urol 1998; 82: 704–9
   PubMedGoogle Scholar
• Bamford MFM, Cruickshank G. Dangers of intranasal desmopressin for nocturnal enuresis. J R Coll Gen Pract 1989; 39: 345–6
   PubMedGoogle Scholar
• Beach PS, Beach RE, Smith LR. Hyponatremic seizures in a child treated with desmopressin to control enuresis. A rational approach to fluid intake. Clin Pediatr (Phila) 1992; 31: 566–9
   PubMed Web of Science ®Google Scholar
• Blanchard P, Brossier JP. Convulsion par hyponatremie profonde au cours d'un traitment par desmopressine nasale pour enuresie. Arch Fr Pediatr 1991; 48: 589
   PubMedGoogle Scholar
• Davis RC. Nocturnal enuresis. Lancet 1992; 340: 1550
   PubMed Web of Science ®Google Scholar
• Donoghue MB, Latimer E, Pilsbury HL, Hertzog JH. Hyponatremic seizures in a child using desmopressin for nocturnal enuresis. Acta Pediatr Adolesc Med 1998; 152: 290–2
   PubMedGoogle Scholar
• Guillaud R, Amram S, Lememme F, Lesbros D. Desmopressine et intoxication par l'eau. A propos d'un cas traitè pour enuresie. Pediatrie 1993; 48: 697–9
   PubMedGoogle Scholar
• Hamed M, Mitchell H. Hyponatremic convulsion associated with desmopressin and imipramine treatment. Br Med J 1993; 306: 1169
   PubMedGoogle Scholar
• Kallio J, Rautava P, Huupponen R, Korvenranta H. Severe hyponatremia caused by intranasal desmopressin for nocturnal enuresis. Acta Paediatr 1993; 82: 881–2
   PubMed Web of Science ®Google Scholar
• Molinari PP, Lambertini A, Giovannini G, Magnani C, Ambrosioni G. La desmopressina e l'enuresi notturna. Medico e bambino 1998; 16: 23–4
   Google Scholar
• Muglia L, Goodman E, Peters C, Majzoub J. Symptomatic hyponatremia secondary to DDAVP treatment for primary enuresis. Pediatr Res 1992; 31: 81A
   Google Scholar
• Robson WLM, Shashi V, Nagaraj S, Norgaard JP. Water intoxication in a patient with the Prader-Willi syndrome treated with desmopressin for nocturnal enuresis. J Urol 1997; 157: 646–7
   PubMed Web of Science ®Google Scholar
• Segal-Kuperschmit D, Dali-Gotfrid O, Luder A. Water intoxication following desmopressin overdose. Harefuah 1997; 132: 465–7, (in Hebrew)
   PubMedGoogle Scholar
• Simmonds EJ, Mahony MJ, Littlewood JM. Convulsion and coma after intranasal desmopressin in cystic fibrosis. Br Med J 1998; 297: 1614
   Google Scholar
• Yaouyanc G, Jonville AP, Yaouyanc-Lapalle H, Barbier P, Dutertre JP, Autret E. Seizures with hyponatremia in a child prescribed desmopressin for nocturnal enuresis. Clin Toxicol 1992; 30: 637–4
   Web of Science ®Google Scholar
• Williford SL, Barnstein SA. Intranasal desmopressin-induced hyponatremia. Pharmacotherapy 1996; 16: 66–74
   PubMed Web of Science ®Google Scholar
• Wagner A, Skriver EB, Pedersen H. Acute water intoxication caused by intranasal desmopressin–Minirine. Ugeskr Laeger 1997; 159: 2889, (in Danish)
   PubMedGoogle Scholar
• Apakama DC, Bleetman A. Hyponatremic convulsion secondary to desmopressin treatment for primary enuresis. J Accid Emerg Med 1999; 16: 229–30
   PubMedGoogle Scholar
• Schwab M, Wenzel D, Ruder H. Hyponatremia and cerebral convulsion due to short term DDAVP therapy for control of enuresis nocturna. Eur J Pediatr 1996; 155: 46–8
   PubMed Web of Science ®Google Scholar
• Sommantico M, D'auria L, Del Gado G, Polidori G, Stabile D, Del Gado R. Il DDAVP nel trattamento dell'enuresi: non si verificano effetti collaterali importanti se. Italian Journal of Pediatrics 1999; 25: 34–5
   Google Scholar
• Del Gado, R, Vernì, M, Ferrara, P, Chiozza, ML, Biraghi, MG, Santucci, A, et al. Indagine multicentrica di post-marketing surveillance (PMS) sull'impiego di DDAVP nell'enuresi notturna. Obiettivo tollerabilità. “Incontri Pediatrici Normanni” Volume degli atti. Aversa 2001; 347.
   Google Scholar
• Dimson SB. Desmopressin as a treatment for enuresis. Lancet 1977; i: 1260
   Google Scholar
• Tuvemo T. DDAVP in childhood nocturnal enuresis. Acta Paediatr Scand 1978; 67: 753–5
   PubMed Web of Science ®Google Scholar
• Norgaard JP, Ritting S, Djurhuus JC. Nocturnal enuresis: an approach to treatment based on pathogenesis. J Pediatr 1989; 114: 705–10
   PubMed Web of Science ®Google Scholar
• Norgaard JP, Pedersen EB, Djurhuus JC. Diurnal antidiuretic hormone levels in enuretics. J Urol 1985; 134: 1029–31
   PubMed Web of Science ®Google Scholar
• Ritting S, Knudsen UB, Norgaard JP, Pedersen EB, Djurhuus JC. Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol 1989; 256: F664–71
   PubMedGoogle Scholar
• Norgaard JP. Pathophysiology of nocturnal enuresis. Scand J Urol Nephrol Suppl 1991; 140: 1–35
   PubMedGoogle Scholar
• Frokiaer J, Nielsen S. Do aquaporins have a role in nocturnal enuresis?. Scand J Urol Nephrol Suppl 1997; 183: 31–2
   PubMedGoogle Scholar
• Muller D, Marr N, Ankermann T, Eggert P, Deen PM. Desmopressin for nocturnal enuresis in nephrogenic diabetes insipidus. Lancet 2002; 359: 495–7
   PubMed Web of Science ®Google Scholar
• Davis ID, MacRae Dell K. Are aquaporin water channels the “holy grail” of primary nocturnal enuresis?. J Urol 2002; 167: 1451–2
   PubMed Web of Science ®Google Scholar
• Deen PM, Dahl N, Caplan MJ. The aquaporin-2 water channel in autosomal dominant primary nocturnal enuresis. J Urol 2002; 167: 1447–50
   PubMed Web of Science ®Google Scholar
• Radetti G, Paganini C, Rigon F, Gentili L, Gebert U, Ishikawa S. Urinary aquaporin-2 excretion in nocturnal enuresis. Eur J Endocrinol 2001; 145: 435–8
   PubMed Web of Science ®Google Scholar
• Robson WLM, Leung AKC. Side effects associated with DDAVP treatment of nocturnal enuresis. J Singapore Pediatr Surg 1994; 36: 81–4
   Google Scholar
• Moffat ME, Harlos S, Kirshen AJ, Burd L. Desmopressin acetate and nocturnal enuresis: how much do we know?. Pediatrics 1993; 32: 5–9
   Google Scholar
• Tullus K, Bergstrom R, Fosdal I, Winnegard I, Hjalmas K. Efficacy and safety during long-term treatment of primary monosymptomatic nocturnal enuresis with desmopressin. Acta Paediatr 1999; 88: 1274–8
   PubMed Web of Science ®Google Scholar
• Nappo S, Chiozza ML, Passerini Glazel G. Desmopressin and side effects: reality or malpractice?. BJU Int 2000; 85: 41–2
   Google Scholar
• Robson WLM, Norgaard JP, Leung AKC. Hyponatremia in patients with nocturnal enuresis treated with DDAVP. Eur J Pediatr 1996; 155: 959–62
   PubMed Web of Science ®Google Scholar
• Fjellstad-Paulsen A, Wille S, Harris S. Comparison of intranasal and oral desmopressin for nocturnal enuresis. Arch Dis Child 1987; 62: 674–7
   PubMed Web of Science ®Google Scholar
• Matthiesen TB, Ritting S, Djurhuus JC, Norgaard JP. A dose titration and an open 6-week efficacy and safety study of desmopressin tablets in the management of nocturnal enuresis. J Urol 1994; 151: 460–3
   PubMed Web of Science ®Google Scholar